ENO2 and pachyonychia congenita: Due to the significant effect of focal NED on disease-specific and overall survival outcomes in some of the included studies in our review, serum neuroendocrine markers such as CgA and NSE might be considered as tumor markers for monitoring of PC patients who harbor focal NED on their RP [37].